Mehras Akhavan, MD
Physical Medicine and Rehabilitation · Sherman Oaks
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 36 years
- Graduated 1990
Offices
1 location
Hospitals listed: 553181 · 757089 · Encino Hospital Medical Center · 05t158. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Akhavan’s office at (818) 990-9050 to ask if they take your plan before you enroll.
California Medical Board record
Licence A82275 · Current
Licensed to practise in California · since 2003 · expires 2028-09-30 · National University of Iran Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Sherman Oaks Ambulatory Surgery CenterAmbulatory Surgery Center · Sherman Oaks, CAOwner · accredited by JCInitial Accreditation2 inspections, 2 with deficiencies · last 2017-01-05: Requirements Met
- Sherman Oaks Ambulatory Surgery CenterAmbulatory Surgery Center · Sherman Oaks, CA100% owner since 2020 · accredited by AAAASFInitial Accreditation2 inspections, 2 with deficiencies · last 2025-07-08
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Encino Hospital Medical CenterEncino, CAAcute Care Hospital · Proprietary · No emergency departmentPart of Prime Healthcare Services, which runs 45 hospitals in 14 statesPatients rate it 1 of 5 · 55% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Encino Hospital Medical Center
Behind the star rating — Deaths: 1 better, 2 the same, 0 worse of 3 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 4 the same, 0 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0 to 2.11) · 108 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.94 (0.51 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.1 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 77 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.6 · 168 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 409 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.47) · 1,449 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.19 (0.67 to 5.71) · 129 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.28 (0.57 to 4) · 127 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 1.2) · 1,023 cases | No different | Jul 2022 – Jun 2024 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 75 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -8.6 · 88 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.2 · 176 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 161 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 37 cases | None | Jul 2023 – Jun 2025 |
What patients said (146 patients answered, 16% of those asked)
| Cleanliness | 3 |
| Nurse communication | 1 |
| Doctor communication | 1 |
| Communication about medicines | 1 |
| Discharge information | 1 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 1 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 62% |
| Doctors "always" communicated well | 64% |
| Staff "always" explained | 47% |
| Yes, staff "did" give patients this information | 75% |
| Yes, staff "did" give patients information about help after discharge | 70% |
| Doctors "always" explained things so they could understand | 58% |
| Doctors "always" listened carefully | 63% |
| Doctors "always" treated them with courtesy and respect | 72% |
| Patients who gave a rating of "9" or "10" (high) | 51% |
| Staff "always" explained new medications | 65% |
| Nurses "always" explained things so they could understand | 55% |
| Nurses "always" listened carefully | 58% |
| Nurses "always" treated them with courtesy and respect | 73% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 55% |
| Staff "always" explained possible side effects | 30% |
| Yes, staff "did" give patients information about possible symptoms | 81% |
Original Medicare doctor bills
$78,780
Medicare paid this office $78,780 for 147 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 77 | $41,654 | $65 |
| Short return visit (20+ min) | 49 | $19,309 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 66 | $7,168 | $107 |
| Aspiration and/or injection of fluid from large joint | 18 | $2,113 | $68 |
| New patient visit (30+ min) | 16 | $1,533 | $96 |
See all 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 77 | $41,654 | $65 |
| Short return visit (20+ min) | 49 | $19,309 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 66 | $7,168 | $107 |
| Aspiration and/or injection of fluid from large joint | 18 | $2,113 | $68 |
| New patient visit (30+ min) | 16 | $1,533 | $96 |
| Short return visit | 17 | $1,330 | $48 |
| Injection of substance into lower spine canal using imaging guidance | 11 | $993 | $71 |
| Injection of trigger points, 3 or more muscles | 13 | $892 | $50 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 29 | $179 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 43 | 40 | 49 | 41 | 21 | 31 |
| Injection of substance into lower spine canal using imaging guidance | 36 | 32 | 28 | 20 | 25 | 14 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 21 | 15 | – | 13 | – | – |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 21 | – | – | 13 | – | – |
| Injection of trigger points, 3 or more muscles | – | – | – | – | – | 18 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | – | – | – | 16 | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
147 Original Medicare patients in 2024. Average age 76 · Under 65 9% · 85 and older 27% · Women 59% · Also on Medicaid 56% · Health risk score 1.86. Above the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 1.53.
Conditions among them: High blood pressure 75% · Diabetes 50% · Coronary heart disease 50% · Depression 50% · Heart failure 41% · Chronic kidney disease 33% · Dementia 31% · COPD 27% · Atrial fibrillation 23% · Stroke 20% · Cancer 17%.
The office billed $437,060, Medicare allowed $99,724 and paid $78,780; for 1,372 services of 21 kinds; $1,619 of it was for drugs given in the office and $77,161 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 147 | 1,372 | 76 | 1.86 | $437,060 | $78,780 |
| 2023 | 146 | 1,492 | 75 | 1.92 | $505,600 | $83,886 |
| 2022 | 158 | 1,381 | 76 | 1.95 | $545,050 | $79,379 |
| 2021 | 172 | 1,751 | 76 | 1.69 | $573,485 | $92,562 |
| 2020 | 166 | 2,952 | 74 | 2.03 | $648,190 | $106,074 |
| 2019 | 217 | 4,886 | 75 | 2.06 | $812,438 | $138,446 |
| 2018 | 261 | 4,685 | 74 | 2.01 | $945,063 | $160,920 |
| 2017 | 232 | 3,517 | 72 | 2.09 | $855,898 | $131,377 |
| 2016 | 192 | 1,833 | 67 | 1.83 | $312,430 | $78,708 |
| 2015 | 191 | 2,161 | 68 | 2.13 | $250,472 | $74,660 |
| 2014 | 232 | 2,573 | 69 | 2.66 | $318,890 | $99,522 |
| 2013 | 276 | 1,947 | 71 | 2.77 | $346,930 | $114,980 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 74 | $45,342 | $66 |
| Short return visit (20+ min) | 60 | $21,331 | $76 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 65 | $7,401 | $109 |
| Injection of substance into lower spine canal using imaging guidance | 17 | $1,977 | $79 |
| New patient visit (30+ min) | 17 | $1,637 | $96 |
| Aspiration and/or injection of fluid from large joint | 13 | $1,578 | $75 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 29 | $270 | None |
2022: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 68 | $31,762 | $61 |
| Short return visit (20+ min) | 70 | $25,506 | $78 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 62 | $7,230 | $115 |
| Aspiration and/or injection of fluid from large joint | 23 | $2,760 | $67 |
| New patient visit (30+ min) | 23 | $2,188 | $95 |
| Injection of substance into lower spine canal using imaging guidance | 16 | $1,708 | $85 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 11 | $1,563 | $98 |
| Hospital discharge day management, 30 minutes or less | 22 | $1,357 | $62 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 12 | $1,250 | $96 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 12 | $745 | $57 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 30 | $243 | None |
2021: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 91 | $39,587 | $61 |
| Short return visit (20+ min) | 60 | $22,037 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 87 | $10,808 | $116 |
| Hospital discharge day management, 30 minutes or less | 79 | $5,296 | $62 |
| Aspiration and/or injection of fluid from large joint | 27 | $3,269 | $67 |
| Injection of substance into lower spine canal using imaging guidance | 23 | $2,420 | $86 |
| New patient visit (30+ min) | 18 | $1,791 | $100 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 31 | $235 | None |
2020: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 79 | $46,232 | $62 |
| Short return visit (20+ min) | 76 | $19,943 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 66 | $7,869 | $117 |
| Injection of substance into lower spine canal using imaging guidance | 24 | $7,593 | $237 |
| Hospital discharge day management, 30 minutes or less | 76 | $4,925 | $63 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 12 | $3,108 | $207 |
| Aspiration and/or injection of fluid from large joint | 20 | $2,464 | $62 |
| New patient visit (30+ min) | 17 | $1,619 | $95 |
| Telephone medical discussion with physician, 5-10 minutes | 20 | $832 | $26 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 49 | $670 | None |
| Testing for presence of drug, read by direct observation | 20 | $311 | $12 |
2019: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 108 | $51,679 | $62 |
| Short return visit (20+ min) | 89 | $26,889 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 105 | $13,092 | $116 |
| Injection of substance into lower spine canal using imaging guidance | 25 | $8,179 | $227 |
| Hospital discharge day management, 30 minutes or less | 108 | $7,193 | $63 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 14 | $4,443 | $212 |
| Aspiration and/or injection of fluid from large joint | 23 | $2,292 | $53 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 14 | $2,259 | $108 |
| New patient visit (30+ min) | 23 | $2,030 | $88 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 63 | $1,137 | None |
| Testing for presence of drug, read by direct observation | 16 | $210 | $12 |
2018: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 124 | $71,495 | $60 |
| Short return visit (20+ min) | 110 | $29,520 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 93 | $11,259 | $113 |
| Injection of substance into lower spine canal using imaging guidance | 29 | $7,529 | $215 |
| Hospital discharge day management, 30 minutes or less | 111 | $7,008 | $61 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 16 | $4,983 | $208 |
| New patient visit (30+ min) | 39 | $3,557 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,840 | $86 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 11 | $2,768 | $213 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 16 | $2,485 | $104 |
| Aspiration and/or injection of fluid from large joint | 18 | $2,194 | $56 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 62 | $1,191 | None |
| Testing for presence of drug, read by direct observation | 33 | $488 | $13 |
2017: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 97 | $44,810 | $59 |
| Short return visit (20+ min) | 103 | $31,317 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 92 | $10,598 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $10,396 | $85 |
| Hospital discharge day management, 30 minutes or less | 78 | $4,839 | $60 |
| Injection of substance into lower spine canal using imaging guidance | 13 | $3,798 | $211 |
| New patient visit (30+ min) | 37 | $3,336 | $90 |
| Aspiration and/or injection of fluid from large joint | 19 | $1,946 | $59 |
| Injection of substance into lower spine canal using imaging guidance | 19 | $1,628 | $78 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 11 | $1,555 | $111 |
| Short return visit | 26 | $1,327 | $37 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 11 | $857 | $61 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 42 | $677 | None |
| Testing for presence of drug, read by direct observation | 14 | $205 | $15 |
2016: 11 services
| Short return visit (20+ min) | 131 | $38,809 | $61 |
| New patient visit (45+ min) | 41 | $5,665 | $138 |
| Injections of substances into lower or sacral spine | 20 | $5,097 | $196 |
| Return visit (30+ min) | 40 | $4,422 | $88 |
| New patient visit (30+ min) | 45 | $4,122 | $92 |
| Aspiration and/or injection of fluid from large joint | 24 | $3,936 | $60 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 13 | $3,403 | $189 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 11 | $3,034 | $217 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 11 | $1,502 | $107 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 62 | $1,054 | None |
| Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures, (eg immunoassay) capable of being read by direct optical observation only (eg, dipsticks, cups, cards, cartridges), includes sample validation when performed, per | 19 | $291 | $15 |
2015: 16 services
| Short return visit (20+ min) | 96 | $22,215 | $62 |
| Return visit (30+ min) | 60 | $10,563 | $90 |
| New patient visit (45+ min) | 31 | $4,336 | $140 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 15 | $3,943 | $188 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 24 | $3,854 | $37 |
| Aspiration and/or injection of fluid from large joint | 27 | $3,130 | $58 |
| New patient visit (30+ min) | 35 | $2,961 | $85 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 11 | $2,818 | $141 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 23 | $2,524 | $110 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 14 | $1,852 | $93 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 11 | $1,618 | $58 |
| Short return visit | 19 | $1,207 | $38 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 61 | $925 | None |
| Injection of trigger points, 3 or more muscles | 11 | $884 | $55 |
| Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter | 33 | $640 | $19 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 22 | $6 | $0 |
2014: 20 services
| Return visit (30+ min) | 93 | $27,165 | $91 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 45 | $10,943 | $58 |
| Short return visit (20+ min) | 60 | $9,802 | $62 |
| New patient visit (45+ min) | 56 | $7,550 | $135 |
| Ultrasonic guidance for needle placement | 25 | $4,134 | $65 |
| Aspiration and/or injection of fluid from large joint | 30 | $4,063 | $58 |
| Complete ultrasound scan of joint | 24 | $4,042 | $106 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 36 | $3,435 | $37 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 29 | $3,227 | $111 |
| Short return visit | 22 | $1,621 | $38 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,611 | $115 |
| Muscle electrical test | 11 | $1,527 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,206 | $60 |
| New patient visit (30+ min) | 12 | $1,106 | $92 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $1,016 | $78 |
| Injection of trigger points, 3 or more muscles | 11 | $996 | $55 |
| Injections of substances into lower or sacral spine | 13 | $919 | $61 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 14 | $677 | $34 |
| Aspiration and/or injection of fluid from large joint | 13 | $627 | $42 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 38 | $485 | None |
2013: 17 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 90 | $20,377 | $57 |
| Short return visit (20+ min) | 68 | $19,023 | $62 |
| Return visit (30+ min) | 63 | $17,209 | $90 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 120 | $13,018 | $108 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 92 | $10,933 | $37 |
| Ultrasonic guidance for needle placement | 11 | $5,403 | $186 |
| New patient visit (45+ min) | 29 | $4,025 | $139 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day at least 25 minutes | 38 | $2,885 | $76 |
| Aspiration and/or injection of fluid from large joint | 20 | $2,519 | $63 |
| Complete ultrasound scan of joint | 13 | $2,097 | $110 |
| Injections of substances into lower or sacral spine | 14 | $2,038 | $75 |
| Short return visit | 21 | $1,514 | $38 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 11 | $1,495 | $136 |
| New patient visit (30+ min) | 15 | $1,375 | $92 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 13 | $653 | $33 |
| Aspiration and/or injection of fluid from large joint | 11 | $563 | $40 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 27 | $329 | None |
Medicaid work
$0 in 2020
Medicaid paid $0 for 12 billed services this clinician did in 2020, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 12 | $0 |
| 2020 | 12 | 1 | 12 | $0 |
| 2018 | 356 | 1 | 37 | $4,070 |
See the largest Medicaid services in earlier years
2018
| Short return visit (20+ min) | 356 | $4,070 |
Drugs they prescribed that Part D paid
$49,498
Pharmacies billed $49,498 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 57% of their Part D prescriptions (447 of 787) in 2024. A higher opioid share than 9 in 10 peers; the typical physical medicine and rehabilitation clinician is at 12%. Long-acting opioids: 16% of their opioid prescriptions.
729 generic and 58 brand-name prescriptions · $49,498 in drug cost · 13 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Diclofenac Epolamine | 25 | $11,657 | $466 |
| Hydrocodone-Acetaminophen | 148 | $2,991 | $20 |
| Oxycodone-Acetaminophen | 90 | $2,034 | $23 |
| Celecoxib | 24 | $1,086 | $45 |
| Pregabalin | 28 | $886 | $32 |
See all 18 drugs
| Diclofenac Epolamine | 25 | $11,657 | $466 |
| Hydrocodone-Acetaminophen | 148 | $2,991 | $20 |
| Oxycodone-Acetaminophen | 90 | $2,034 | $23 |
| Celecoxib | 24 | $1,086 | $45 |
| Pregabalin | 28 | $886 | $32 |
| Hydromorphone | 26 | $767 | $29 |
| Morphine Sulfate Er | 36 | $569 | $16 |
| Gabapentin | 41 | $543 | $13 |
| Methocarbamol | 29 | $498 | $17 |
| Methadone | 31 | $462 | $15 |
| Oxycodone | 34 | $343 | $10 |
| Acetaminophen-Codeine | 28 | $272 | $10 |
| Tramadol | 48 | $226 | $5 |
| Duloxetine | 13 | $204 | $16 |
| Cyclobenzaprine | 13 | $100 | $8 |
| Zolpidem | 14 | $89 | $6 |
| Trazodone | 23 | $40 | $2 |
| Temazepam | 11 | $31 | $3 |
Year by year
| 2024 | 787 | 72 | 57% (447) | 7% | $49,498 |
| 2023 | 848 | 86 | 59% (501) | 5% | $39,039 |
| 2022 | 994 | 102 | 54% (540) | None | $41,038 |
| 2021 | 961 | 103 | 56% (540) | None | $32,037 |
| 2020 | 1,131 | 127 | 54% (608) | None | $43,948 |
| 2019 | 1,458 | 152 | 55% (808) | 12% | $86,160 |
| 2018 | 2,224 | 225 | 55% (1,220) | 12% | $143,789 |
| 2017 | 2,775 | 219 | 59% (1,625) | 10% | $178,052 |
| 2016 | 2,438 | 219 | 62% (1,504) | 11% | $183,686 |
| 2015 | 1,771 | 170 | 62% (1,095) | None | $149,032 |
| 2014 | 1,539 | 137 | 62% (949) | None | $124,747 |
| 2013 | 1,574 | 117 | 67% (1,056) | 27% | $132,638 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Lidocaine | 22 | $9,290 | $422 |
| Hydrocodone-Acetaminophen | 136 | $3,266 | $24 |
| Oxycodone-Acetaminophen | 108 | $3,029 | $28 |
| Pregabalin | 36 | $2,569 | $71 |
| Morphine Sulfate Er | 48 | $1,581 | $33 |
| Gabapentin | 56 | $1,056 | $19 |
| Fentanyl | 11 | $913 | $83 |
| Celecoxib | 17 | $757 | $45 |
| Methadone | 36 | $716 | $20 |
| Hydromorphone | 26 | $693 | $27 |
| Tramadol | 71 | $546 | $8 |
| Duloxetine | 28 | $541 | $19 |
| Oxycodone | 46 | $469 | $10 |
| Cyclobenzaprine | 23 | $270 | $12 |
| Acetaminophen-Codeine | 17 | $251 | $15 |
| Sumatriptan | 12 | $245 | $20 |
| Methocarbamol | 13 | $182 | $14 |
| Zolpidem | 11 | $172 | $16 |
| Prednisone | 11 | $93 | $8 |
2022: 23 drugs
| Lidocaine | 21 | $9,001 | $429 |
| Oxycodone-Acetaminophen | 133 | $3,987 | $30 |
| Pregabalin | 71 | $3,271 | $46 |
| Hydrocodone-Acetaminophen | 137 | $2,652 | $19 |
| Fentanyl | 12 | $1,310 | $109 |
| Morphine Sulfate Er | 47 | $1,306 | $28 |
| Gabapentin | 59 | $1,013 | $17 |
| Hydromorphone | 25 | $933 | $37 |
| Methocarbamol | 29 | $912 | $31 |
| Methadone | 48 | $742 | $15 |
| Oxycodone | 49 | $648 | $13 |
| Cyclobenzaprine | 30 | $566 | $19 |
| Sumatriptan | 20 | $483 | $24 |
| Celecoxib | 11 | $387 | $35 |
| Tramadol | 63 | $358 | $6 |
| Butalb-Acetaminoph-Caff-Codein | 14 | $348 | $25 |
| Acetaminophen-Codeine | 12 | $306 | $25 |
| Diclofenac | 11 | $274 | $25 |
| Duloxetine | 17 | $159 | $9 |
| Meloxicam | 21 | $149 | $7 |
| Trazodone | 16 | $79 | $5 |
| Diazepam | 14 | $71 | $5 |
| Zolpidem | 16 | $70 | $4 |
2021: 21 drugs
| Lidocaine | 23 | $6,682 | $291 |
| Oxycodone-Acetaminophen | 136 | $3,343 | $25 |
| Hydrocodone-Acetaminophen | 130 | $2,695 | $21 |
| Pregabalin | 40 | $1,761 | $44 |
| Morphine Sulfate Er | 50 | $1,725 | $35 |
| Fentanyl | 11 | $1,352 | $123 |
| Hydromorphone | 33 | $1,245 | $38 |
| Gabapentin | 74 | $1,240 | $17 |
| Baclofen | 23 | $957 | $42 |
| Oxycodone | 48 | $902 | $19 |
| Methadone | 41 | $704 | $17 |
| Cyclobenzaprine | 35 | $575 | $16 |
| Tramadol | 76 | $536 | $7 |
| Celecoxib | 11 | $399 | $36 |
| Pantoprazole | 11 | $271 | $25 |
| Methocarbamol | 13 | $215 | $17 |
| Zolpidem | 21 | $170 | $8 |
| Diazepam | 12 | $74 | $6 |
| Metformin | 12 | $56 | $5 |
| Furosemide | 12 | $29 | $2 |
| Alprazolam | 14 | $22 | $2 |
2020: 24 drugs
| Movantik | 26 | $9,679 | $372 |
| Oxycodone-Acetaminophen | 155 | $4,397 | $28 |
| Pregabalin | 40 | $2,804 | $70 |
| Hydrocodone-Acetaminophen | 150 | $2,152 | $14 |
| Gabapentin | 83 | $2,034 | $25 |
| Fentanyl | 12 | $1,752 | $146 |
| Morphine Sulfate Er | 61 | $1,412 | $23 |
| Hydromorphone | 38 | $1,295 | $34 |
| Oxycodone | 43 | $1,076 | $25 |
| Methadone | 45 | $942 | $21 |
| Cyclobenzaprine | 51 | $826 | $16 |
| Tramadol | 91 | $634 | $7 |
| Baclofen | 22 | $614 | $28 |
| Duloxetine | 15 | $337 | $22 |
| Atorvastatin | 18 | $303 | $17 |
| Alprazolam | 18 | $282 | $16 |
| Methocarbamol | 20 | $220 | $11 |
| Clopidogrel | 12 | $201 | $17 |
| Metoprolol | 13 | $181 | $14 |
| Ondansetron | 15 | $166 | $11 |
| Trazodone | 14 | $129 | $9 |
| Zolpidem | 25 | $100 | $4 |
| Diazepam | 15 | $97 | $6 |
| Ibuprofen | 20 | $62 | $3 |
2019: 24 drugs
| Lyrica | 44 | $31,164 | $708 |
| Oxycodone-Acetaminophen | 241 | $8,073 | $33 |
| Movantik | 17 | $6,169 | $363 |
| Fentanyl | 32 | $3,437 | $107 |
| Gabapentin | 141 | $3,132 | $22 |
| Hydrocodone-Acetaminophen | 175 | $2,894 | $17 |
| Pregabalin | 13 | $2,825 | $217 |
| Morphine Sulfate Er | 77 | $2,638 | $34 |
| Hydromorphone | 59 | $1,951 | $33 |
| Duloxetine | 38 | $1,148 | $30 |
| Tramadol | 116 | $1,087 | $9 |
| Oxycodone | 42 | $1,027 | $24 |
| Methadone | 49 | $747 | $15 |
| Baclofen | 40 | $606 | $15 |
| Diclofenac | 12 | $577 | $48 |
| Zolpidem | 37 | $249 | $7 |
| Cyclobenzaprine | 34 | $237 | $7 |
| Alprazolam | 15 | $204 | $14 |
| Methocarbamol | 13 | $156 | $12 |
| Clonazepam | 31 | $154 | $5 |
| Diazepam | 22 | $96 | $4 |
| Trazodone | 20 | $85 | $4 |
| Ibuprofen | 13 | $78 | $6 |
| Temazepam | 12 | $44 | $4 |
2018: 32 drugs
| Lyrica | 34 | $23,289 | $685 |
| Oxycodone-Acetaminophen | 347 | $12,130 | $35 |
| Movantik | 24 | $8,530 | $355 |
| Morphine Sulfate Er | 180 | $7,098 | $39 |
| Fentanyl | 63 | $7,015 | $111 |
| Lidocaine | 12 | $6,031 | $503 |
| Oxycontin | 11 | $5,667 | $515 |
| Gralise | 11 | $5,412 | $492 |
| Hydrocodone-Acetaminophen | 225 | $3,850 | $17 |
| Gabapentin | 258 | $3,466 | $13 |
| Hydromorphone | 73 | $1,665 | $23 |
| Oxycodone | 61 | $1,601 | $26 |
| Baclofen | 65 | $1,542 | $24 |
| Duloxetine | 54 | $1,314 | $24 |
| Voltaren | 19 | $1,044 | $55 |
| Tramadol | 149 | $1,018 | $7 |
| Methadone | 57 | $835 | $15 |
| Nabumetone | 20 | $376 | $19 |
| Cyclobenzaprine | 24 | $329 | $14 |
| Clonazepam | 49 | $250 | $5 |
| Alprazolam | 36 | $249 | $7 |
| Diazepam | 41 | $229 | $6 |
| Zolpidem | 36 | $191 | $5 |
| Methocarbamol | 12 | $136 | $11 |
| Acetaminophen-Codeine | 20 | $132 | $7 |
| Ibuprofen | 15 | $112 | $7 |
| Meloxicam | 22 | $102 | $5 |
| Omeprazole | 11 | $95 | $9 |
| Carisoprodol | 16 | $77 | $5 |
| Temazepam | 14 | $70 | $5 |
| Prednisone | 13 | $35 | $3 |
| Lorazepam | 22 | $29 | $1 |
2017: 35 drugs
| Lyrica | 37 | $23,626 | $639 |
| Oxycontin | 13 | $16,743 | $1,288 |
| Lidocaine | 54 | $16,209 | $300 |
| Fentanyl | 156 | $14,955 | $96 |
| Oxycodone-Acetaminophen | 401 | $13,932 | $35 |
| Morphine Sulfate Er | 279 | $13,751 | $49 |
| Nucynta | 14 | $11,413 | $815 |
| Butrans | 12 | $7,389 | $616 |
| Nucynta Er | 11 | $6,969 | $634 |
| Movantik | 17 | $5,433 | $320 |
| Hydrocodone-Acetaminophen | 279 | $4,316 | $15 |
| Diclofenac | 15 | $3,419 | $228 |
| Gabapentin | 226 | $2,878 | $13 |
| Hydromorphone | 126 | $2,760 | $22 |
| Oxycodone | 65 | $1,863 | $29 |
| Methadone | 84 | $1,631 | $19 |
| Voltaren | 22 | $1,293 | $59 |
| Baclofen | 57 | $1,244 | $22 |
| Duloxetine | 40 | $1,193 | $30 |
| Cyclobenzaprine | 89 | $1,064 | $12 |
| Nabumetone | 30 | $785 | $26 |
| Endocet | 22 | $618 | $28 |
| Tramadol | 102 | $564 | $6 |
| Doxepin | 18 | $429 | $24 |
| Acetaminophen-Codeine | 38 | $386 | $10 |
| Clonazepam | 94 | $374 | $4 |
| Diazepam | 68 | $232 | $3 |
| Alprazolam | 40 | $178 | $4 |
| Meloxicam | 46 | $147 | $3 |
| Temazepam | 22 | $142 | $6 |
| Trazodone | 20 | $127 | $6 |
| Lorazepam | 23 | $110 | $5 |
| Zolpidem | 21 | $82 | $4 |
| Escitalopram | 12 | $54 | $4 |
| Prednisone | 12 | $32 | $3 |
2016: 33 drugs
| Oxycontin | 15 | $24,703 | $1,647 |
| Lyrica | 66 | $24,638 | $373 |
| Nucynta | 28 | $19,077 | $681 |
| Oxycodone-Acetaminophen | 361 | $18,574 | $51 |
| Fentanyl | 158 | $18,117 | $115 |
| Lidocaine | 61 | $17,201 | $282 |
| Morphine Sulfate Er | 266 | $14,032 | $53 |
| Hydrocodone-Acetaminophen | 259 | $5,998 | $23 |
| Opana Er | 11 | $3,210 | $292 |
| Hydromorphone | 62 | $2,607 | $42 |
| Oxycodone | 88 | $2,562 | $29 |
| Gabapentin | 180 | $2,525 | $14 |
| Methadone | 89 | $2,171 | $24 |
| Baclofen | 66 | $1,869 | $28 |
| Nabumetone | 42 | $935 | $22 |
| Modafinil | 12 | $868 | $72 |
| Diclofenac | 25 | $567 | $23 |
| Acetaminophen-Codeine | 36 | $555 | $15 |
| Tramadol | 100 | $522 | $5 |
| Duloxetine | 12 | $445 | $37 |
| Morphine Sulfate | 16 | $380 | $24 |
| Diazepam | 56 | $270 | $5 |
| Cyclobenzaprine | 42 | $209 | $5 |
| Clonazepam | 54 | $156 | $3 |
| Ibuprofen | 23 | $147 | $6 |
| Alprazolam | 38 | $124 | $3 |
| Meloxicam | 30 | $101 | $3 |
| Trazodone | 20 | $84 | $4 |
| Carisoprodol | 20 | $78 | $4 |
| Lorazepam | 22 | $68 | $3 |
| Alendronate | 11 | $68 | $6 |
| Temazepam | 16 | $65 | $4 |
| Prednisone | 11 | $37 | $3 |
2015: 28 drugs
| Oxycontin | 15 | $20,936 | $1,396 |
| Lyrica | 54 | $16,386 | $303 |
| Nucynta | 42 | $15,617 | $372 |
| Fentanyl | 145 | $13,366 | $92 |
| Oxycodone-Acetaminophen | 179 | $12,265 | $69 |
| Morphine Sulfate Er | 161 | $12,124 | $75 |
| Lidocaine | 21 | $7,689 | $366 |
| Hydrocodone-Acetaminophen | 147 | $3,848 | $26 |
| Voltaren | 23 | $3,527 | $153 |
| Hydromorphone | 99 | $3,251 | $33 |
| Oxycodone | 92 | $2,854 | $31 |
| Methadone | 86 | $2,299 | $27 |
| Celecoxib | 16 | $1,666 | $104 |
| Baclofen | 52 | $1,417 | $27 |
| Gabapentin | 70 | $1,399 | $20 |
| Butalbital-Acetaminophen-Caffe | 13 | $644 | $50 |
| Carisoprodol | 37 | $482 | $13 |
| Tramadol | 83 | $417 | $5 |
| Diclofenac | 16 | $336 | $21 |
| Cyclobenzaprine | 23 | $323 | $14 |
| Butalbital-Aspirin-Caffeine | 12 | $321 | $27 |
| Acetaminophen-Codeine | 22 | $268 | $12 |
| Clonazepam | 66 | $210 | $3 |
| Alprazolam | 44 | $125 | $3 |
| Ibuprofen | 22 | $95 | $4 |
| Alendronate | 14 | $90 | $6 |
| Diazepam | 26 | $79 | $3 |
| Trazodone | 18 | $67 | $4 |
2014: 27 drugs
| Oxycontin | 21 | $22,933 | $1,092 |
| Fentanyl | 135 | $17,465 | $129 |
| Morphine Sulfate Er | 125 | $11,323 | $91 |
| Lyrica | 24 | $9,012 | $376 |
| Hydromorphone | 155 | $6,645 | $43 |
| Nucynta | 18 | $5,806 | $323 |
| Celebrex | 24 | $5,196 | $216 |
| Oxycodone | 101 | $4,883 | $48 |
| Oxycodone-Acetaminophen | 76 | $3,361 | $44 |
| Lidocaine | 16 | $3,174 | $198 |
| Hydrocodone-Acetaminophen | 111 | $2,237 | $20 |
| Endocet | 34 | $1,831 | $54 |
| Gabapentin | 55 | $1,364 | $25 |
| Carisoprodol | 57 | $1,361 | $24 |
| Methadone | 88 | $1,028 | $12 |
| Voltaren | 22 | $1,010 | $46 |
| Diclofenac | 29 | $596 | $21 |
| Baclofen | 29 | $452 | $16 |
| Butalbital-Aspirin-Caffeine | 12 | $372 | $31 |
| Alprazolam | 73 | $345 | $5 |
| Butalbital-Acetaminophen-Caffe | 13 | $301 | $23 |
| Nabumetone | 14 | $297 | $21 |
| Tramadol | 45 | $295 | $7 |
| Meperidine | 14 | $220 | $16 |
| Morphine Sulfate | 13 | $208 | $16 |
| Cyclobenzaprine | 20 | $171 | $9 |
| Clonazepam | 24 | $148 | $6 |
2013: 27 drugs
| Oxycontin | 63 | $39,776 | $631 |
| Fentanyl | 103 | $19,482 | $189 |
| Hydromorphone | 200 | $10,372 | $52 |
| Lidoderm | 15 | $8,577 | $572 |
| Oxycodone | 165 | $7,694 | $47 |
| Morphine Sulfate Er | 100 | $7,682 | $77 |
| Celebrex | 43 | $7,082 | $165 |
| Lyrica | 17 | $5,089 | $299 |
| Nucynta | 12 | $4,169 | $347 |
| Gralise | 18 | $3,482 | $193 |
| Hydrocodone-Acetaminophen | 137 | $2,574 | $19 |
| Cymbalta | 13 | $2,522 | $194 |
| Oxycodone Hcl-Acetaminophen | 46 | $2,391 | $52 |
| Methadone | 117 | $1,406 | $12 |
| Gabapentin | 28 | $1,395 | $50 |
| Endocet | 30 | $883 | $29 |
| Lidocaine | 13 | $722 | $56 |
| Carisoprodol | 76 | $638 | $8 |
| Alprazolam | 71 | $487 | $7 |
| Diclofenac | 20 | $407 | $20 |
| Tramadol | 36 | $335 | $9 |
| Oxycodone-Acetaminophen | 23 | $283 | $12 |
| Cyclobenzaprine | 34 | $262 | $8 |
| Ibuprofen | 22 | $124 | $6 |
| Lorazepam | 11 | $76 | $7 |
| Diazepam | 18 | $74 | $4 |
| Clonazepam | 13 | $64 | $5 |
Money from drug and device companies
$20 in 2024
| 2024 | 1 | 1 | None | $20 |
| 2022 | 3 | 4 | None | $74 |
| 2021 | 2 | 3 | None | $73 |
| 2020 | 4 | 7 | None | $161 |
| 2019 | 8 | 10 | None | $226 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Forte Bio-Pharma | Nalocet | $20 | 1 payment
|
See the published payment
| Forte Bio-Pharma | Meals · 2024-05-06 | Nalocet | $20 |
See earlier years (2022, 2021, 2020, 2019)
2022: $74
| Abbvie | Botox | $32 | 2 payments
|
| Scilex Pharmaceuticals | Ztlido | $22 | 1 payment
|
| Lilly USA | Emgality | $20 | 1 payment
|
2021: $73
| Pfizer | None | $52 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $22 | 1 payment
|
2020: $161
| Lilly USA | Emgality | $60 | 3 payments
|
| Pfizer | None | $58 | 2 payments
|
| IBSA Pharma | Tirosint | $22 | 1 payment
|
| RedHill Biopharma | Movantik | $21 | 1 payment
|
2019: $226
| Pfizer | Embeda | $46 | 2 payments
|
| Daiichi Sankyo | Morphabond Er | $45 | 2 payments
|
| Amgen | Aimovig | $35 | 1 payment
|
| Assertio Therapeutics | Cambia | $23 | 1 payment
|
| Bioventus | Gelsyn 3 | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Movantik | $21 | 1 payment
|
| Vertiflex | Superion Iss | $19 | 1 payment
|
| BioDelivery Sciences International | Bunavail 2.1 Mg 30-Count Box | $16 | 1 payment
|
Professional record
- NPI
- 1497817332
- Licence
- CA A82275California A82275: Current · expires 2028-09-30
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2081P2900X (2081P2900X)
- Mailing address
- 4940 Van Nuys Blvd Ste 301, Sherman Oaks, CA, 91403
- NPI first listed
- 2006-12-15
- NPI last updated
- 2012-07-25
This is when the NPI record was last certified, not a medical board exam.